Diluted EPS came in at $-0.35 (-483.3% YoY), missed the $-0.29 consensus by $0.06.
Trailing eight quarters through Q1 2025
Common questions about Pyxis Oncology's Q1 2025 earnings report.
Pyxis Oncology (PYXS) reported Q1 2025 earnings on May 15, 2025 before market open.
Pyxis Oncology reported diluted EPS of $-0.35 for Q1 2025.
EPS missed the consensus estimate of $-0.29 by $0.06.
Compared to the same quarter a year prior, diluted EPS declined 483.3% from $-0.06.
You can read the 10-Q periodic report (0000950170-25-071996) directly on SEC EDGAR. The filing index links above go to sec.gov.